Principles and Practice of Pharmaceutical Medicine

at the age of 14, graduated BA in 1728, became an marketing authorization (MA) in 1732, and obtained his MD in 1739. Heberden pu ...

compulsory for children under the age of 14 years to bevaccinated, and encouraged the notification of default by doctors by prov ...

prohibited: cancer, consumption, lupus, deaf- ness, diabetes, paralysis, fits, epilepsy, locomo- tor ataxy, Bright disease, rupt ...

Act in the United Kingdom and most other modern European states’ legislation, including the European Community’s Directive 65/65 ...

a White Paper,Forthcoming Legislation on the Safety, Quality and Description of Drugs and Med- icines(Cmnd 3393), was published ...

During the period 1971–1981, after the imple- mentation of the Medicines Act (1968), the Licen- sing Authority granted 204 MAs f ...

initiated by them but not at the request of a phar- maceutical company. Outline information about the trial is required and a de ...

A negative effect on phase I clinical research was being reported in the United Kingdom by Clinical Research Organisations (CROs ...

which are relevant to public health protection in Third World countries. MA holder’s responsibilities: To have a qualified pers ...

MA application, as accepted by the authorities. Methods shall be updated in the light of scientific advances, and modifications ...

possess controlled drugs while acting in their pro- fessional capacities, and lay down the conditions under which these activiti ...

Controlled expression of genes coding for bio- logically active proteins in prokaryotates and eukaryotates including transforme ...

Centralized procedure Inthe centralized procedure, productsfalling within AnnexAhavetobeprocessedbythisroute,products in Annex B ...

during 1997. In this procedure, the initial or refer- ence member state that granted marketing approval forwards the necessary d ...

cover (a) chemistry, pharmacy, manufacturing route; (b) preclinical aspects, including pharma- cology, safety pharmacology, phar ...

[COM(97) 183 Fund], the European Commission emphasized thathigh-quality scientific committees are an essential foundation for EC ...

free movement of goods within the EC, that is an industrial/commercial objective. In the future, it might be more logical for th ...

from the IFPMA Offices, 30 Rue du St Jean, P.O. Box 9, 1211 Geneva 18, Switzerland. The clinical guidelines applicable to the EC ...

advisory committee serving the EMEA should be served by expert panels, covering chemistry and pharmacy, pharmacology, and toxico ...

between 1972 and 1994’.Br. J. Clin. Pharmacol.45: 151–156. Munk W. 1878.The Roll of Royal College of Physicians of London, Vol. ...